LobbyingElusys Therapeutics lobbying by quarter
Elusys Therapeutics's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q4 2024; the issues it reports most are Medical/Disease Research/Clinical Labs.
Elusys Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $60K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$140K · 7 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES7 reports
- SENATE7 reports
Firms it paid
| Firm | ||
|---|---|---|
| The Conafay Group | $140K | 7 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRYAN SHUY | Chief of Staff Rep. Harris; Asst. to Rep. Harris, HouseCmteon Approps; Dep. Asst. Sec and Chief of StaffHHS/Asst.Secretary for Preparedness and Response (ASPR) | Q2 2026 |
| DARIN L GARDNER | Legislative Correspondent Senator Tim Hutchinson;ResearchAssistant Senate HELP Committee; Chief ofStaffCongresswoman Kay Granger | Q2 2026 |
| JOSH NARROW | Intern to Senator Casey | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | The Conafay Group | $20K |
| 04/20for Q1 | The Conafay Group | $20K |
| 01/20for Q4 2025 | The Conafay Group | $20K |
| 25/10/17for Q3 2025 | The Conafay Group | $20K |
| 25/07/18for Q2 2025 | The Conafay Group | $20K |
| 25/04/18for Q1 2025 | The Conafay Group | $20K |
| 25/01/17for Q4 2024 | The Conafay Group | $20K |
| 24/10/16for Q4 2024 | The Conafay Group | Under $5,000 |